Study design, materials and methods
SCI patients who experienced recurrent blockages or infections were identified from the records of the Complex Catheter Change Clinic. Following written consent, patients were entered into the Product Evaluation for a period of 12 weeks. They were given information about the device and training in its use. Baseline questionnaires regarding number of blockages and infections, QoL, sleep quality, and catheter satisfaction were completed. Questionnaires were repeated at 4, 8 and 12 weeks. Patient comments were also collected.
Interpretation of results
The Uroshield device prevented catheter blockages and recurrent infections in patients with a supra-pubic catheter. It was well tolerated in the majority of patients, but some stopped due to practical reasons.